cadherin; lung cancer cells; metalloproteinases; tumor invasion; vimentin
Abstract :
[en] The acquisition of a metastatic phenotype by epithelial cells implicates a series of changes altering their differentiation, their overall behavior and morphology. In the present study, we have examined the relationships between the cellular morphology, E-cadherin expression, matrix metalloproteinases expression and in vitro invasive properties in two human bronchial immortalized cell lines. The (16HBE14o-) cell line which did not show any invasive abilities in the Boyden chamber assay displayed a typical epithelial morphology in monolayer, expressed high levels of E-cadherin and synthesized neither MMP-2 and MT1-MMP nor vimentin. In contrast, the BZR cell line which was highly invasive displayed a more elongated phenotype in monolayer, did not produce E-cadherin but expressed vimentin, MMP-2 and MT1-MMP. Our data therefore suggest that the metastatic progression of broncho-pulmonary cancer cells results in a cellular dedifferentiation and the gain of some mesenchymal attributes (loss of E-cadherin and expression of vimentin) associated with enhanced degradative properties (expression of metalloproteinases)
Disciplines :
Biochemistry, biophysics & molecular biology
Author, co-author :
Polette, M.
Gilles, Christine ; Université de Liège - ULiège > Département des sciences cliniques > Labo de biologie des tumeurs et du développement
de Bentzmann, S.
Gruenert, D.
Tournier, J. M.
Birembaut, P.
Language :
English
Title :
Association of fibroblastoid features with the invasive phenotype in human bronchial cancer cell lines
Takeichi M, 1988, The cadherins: cell-cell adhesion molecules controlling animal morphogenesis. Development, 102, 639-55.
Shiozaki H, Oka H, Inoue M, Tamura S and Monden M, 1996, E-cadherin mediated adhesion system in cancer cells. Cancer (suppl.), 77, 1605-13.
Shipper JH, Frixen UH, Behrens J, Unger A, Jahnke K and Birchmeier W, 1991, E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis. Cancer Res, 51, 6328-37.
Oka H, Shiozaki H, Kobayashi K et al. 1993, Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res, 53, 1696-1701.
Frixen UH, Behrens J, Sachs M et al. 1991, E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol, 113, 173-85.
Sommers CL, Thompson EW, Torri JA et al. 1991, Cell adhesion molecule uvomorulin expression in human breast cancer cell lines: relationship to morphology and invasive capacities. Cell Growth Different, 2, 365-71.
Vlemincks K, Vakaet, LJ, Marcel M, Fiers W and Van Roy RF, 1991, Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell, 66, 107-19.
Behrens J, Mareel MM, Van Roy FM and Birchmeier W, 1989, Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin. J Cell Biol, 108, 2435-47.
Polette M and Birembaut P, 1996, Metalloproteinases and breast carcinomas. Breast J, 2, 1-13.
Stetler-Stevenson WG, 1990. Type IV collagenases in tumor invasion and metastasis. Cancer Metastasis Rev, 9, 289-303.
Brown PD, Bloxridge RE, Anderson E and Howell A, 1993, Expression of activated gelatinase in human invasive breast carcinoma. Clin Exp Metastasis, 11, 183-9.
Davies B, Miles DW, Happerfield LC, et al. 1993, Activity of type IV collagenases in benign and malignant breast disease. Br J Cancer, 67, 1126-31.
Azzam H, Arrand GA, Lippman ME and Thompson EW, 1993, MMP-2 activation potential associates with metastatic progression in human breast cancer cell lines, and is independent of MMP-2 production. J Natl Cancer Inst, 85, 1758-64.
Gilles C, Polette M, Piette J, Birembaut P and Foidart JM, 1994, Epithelial to mesenchymal transition in HPV-33-transfected cervical keratinocytes is associated with increased invasiveness and expression of gelatinase A. Int J Cancer, 59, 661-6.
Yu M, Sato H, Seiki M and Thompson EW, 1995, Complex regulation of membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation by concanavalin in MDA-MB-231 human breast cancer cells. Cancer Res, 55, 3272-7.
Sato H, Takino T, Okada Y et al. 1994, A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature, 370, 61-5.
Gilles C, Polette M, Piette J et al. 1996, High level of MT-MMP expression is associated with invasiveness of cervical cancer cells. Int J Cancer, 65, 209-13.
Yamamoto M, Mahanam S, Sawaya R et al. 1996, Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro. Cancer Res, 56, 384-92.
Okada A, Bellocq JP, Rouyer N et al. 1995, Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas. Proc Natl Acad Sci USA, 92, 2730-4.
Nomura H, Sato H, Seiki M, Mai M and Okada Y, 1995, Expression of membrane type matrix metalloproteinase in human gastric carcinomas. Cancer Res, 55, 3263-6.
Polette M, Nawrocki B, Gilles C et al. 1996, MT-MMP expression and localisation in human breast and lung cancers. Virchows Arch, 428, 29-35.
Cozens AL, Yezzi MJ, Kunzelmann K et al. 1994, CFTR expression and chloride secretion in polarized immortalized human bronchial epithelial cells. Am J Respir Cell Mol Biol, 10, 38-47.
Ura H, Bonfil RD, Reich R et al. 1989, Expression of type IV collagenase and procollagen genes and its correlation with the tumorigenic, invasive, and metastatic abilities of oncogene-transformed human bronchial epithelial cells. Cancer Res, 49, 4615-21.
Kleinman HK, McGarvey ML, Hasel JR et al. 1986, Bm complexes with biological activity. Biochemistry, 5, 312-18.
Gamello C, Palacios J, Suaerz A et al. 1993, Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. Am J Pathol, 142, 987-93.
Böhm M, Tozeck B, Birchmeier W and Wiesland I, 1994. Differences of E-cadherin expression levels and patterns in primary and metastatic human lung cancer. Clin Exp Metastasis, 12, 55-62.
Thompson EW, Paik S, Brünner N et al. 1992, Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines. J Cell Physiol, 150, 534-44.
Bae NS, Arand G, Azzam H, et al. 1993, Molecular and cellular analysis of basement membrane invasion by human breast cancer cells in Matrigel-based in vitro assays. Breast Cancer Res Treat, 24, 214-55.
Sommers CL, Byers SW, Thompson EW, Torri JA and Gelmann EP, 1994, Differentiation state and invasiveness of human breast cancer cell lines. Breast Cancer Res Treat, 31, 325-35.
Gilles C and Thompson EW, 1996, The epithelial to mesenchymal transition and metastatic progression in carcinoma. Breast J, 2, 83-96.
Guarino M, 1995, Epithelial-to-mesenchymal change of differentiation. From embryogenetic mechanism to pathological patterns. Hist Histopathol, 10, 171-84.
Thiery JP, Duband JL and Tucker GC, 1985, Cell migration in the vertebrate embryo: role of cell adhesion and tissue environment in pattern formation. Ann Rev Cell Biol, 110, 91-113.
Buisson AC, Gilles C, Polette M, Zahm JM, Birembaut P and Tournier JM, 1996, Wound repair-induced expression of stromelysins is associated with the acquisition of a mesenchymal phenotype in human respiratory epithelial cells. Lab Invest, 74, 658-69.
Nawrocki B, Polette M, Marchand V et al. 1997, Expression of matrix metalloproteinases and their inhibitors in human broncho-pulmonary carcinomas: quantitative and morphological analyses. Int J Cancer (in press).
Crawford HC and Matrisian LM, 1994, Tumor and stromal expression of matrix metalloproteinases and their role in tumor progression. Inv Metastasis, 14, 234-45.